Costs and prolonged length of stay of central venous catheter-associated bloodstream infections (CVC BSI): A matched prospective cohort study

Infection

Volumn 42, Issue 1, 2014, Pages 31-36

  Leistner, R ^a   Hirsemann, E ^a   Bloch, A ^a   Gastmeier, P ^a   Geffers, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Central venous catheter associated blood stream infection; Costs and length of stay; Intensive care unit

Indexed keywords

ADULT; AGED; ARTICLE; BLOODSTREAM INFECTION; CENTRAL VENOUS CATHETER; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HOSPITAL COST; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SIMPLIFIED ACUTE PHYSIOLOGY SCORE;

ADOLESCENT; AGED; AGED, 80 AND OVER; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; COHORT STUDIES; FEMALE; HEALTH CARE COSTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84898541553     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0494-z     Document Type: Article

References (19)

1. Rosenthal VD, Maki DG, Graves N. The International Nosocomial Infection Control Consortium (INICC): goals and objectives, description of surveillance methods, and operational activities. Am J Infect Control. 2008;36:e1-12. doi:10.1016/j.ajic.2008.06.003.
2. Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005;41:1591-8. doi:10.1086/497833. (Pubitemid 41693760)
3. Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med. 2006;34:2084-9. doi:10.1097/01.CCM.0000227648.15804.2D. (Pubitemid 44305609)
4. Pirson M, Dramaix M, Struelens M, Riley TV, Leclercq P. Costs associated with hospital-acquired bacteraemia in a Belgian hospital. J Hosp Infect. 2005;59:33-40. doi:10.1016/j.jhin.2004.07.006. (Pubitemid 39618963)
5. Pirson M, Leclercq P, Jackson T, Leclercq M, Garrino M, Sion C. Financial consequences of hospital-acquired bacteraemia in three Belgian hospitals in 2003 and 2004. J Hosp Infect. 2008;68:9-16. doi:10.1016/j.jhin.2007.10.006.
6. Vrijens F, Hulstaert F, Van de Sande S, Devriese S, Morales I, Parmentier Y. Hospital-acquired, laboratory-confirmed blood-stream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs. J Hosp Infect. 2010;75:158-62. doi:10.1016/j.jhin.2009.12.006.
7. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med. 1999;160:976-81. (Pubitemid 29442039)
8. Higuera F, Rangel-Frausto MS, Rosenthal VD, Soto JM, Castanon J, Franco G, et al. Attributable cost and length of stay for patients with central venous catheter-associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hosp Epidemiol. 2007;28:31-5. doi:10.1086/510812. (Pubitemid 46219222)
9. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271:1598-601.
10. Zuschneid I, Rücker G, Schoop R, Beyersmann J, Schumacher M, Geffers C, et al. Representativeness of the surveillance data in the intensive care unit component of the German nosocomial infections surveillance system. Infect Control Hosp Epidemiol. 2010;31:934-8. doi:10.1086/655462.
11. Gastmeier P, Geffers C, Sohr D, Dettenkofer M, Daschner F, Rüden H. Five years working with the German nosocomial infection surveillance system (Krankenhaus Infektions Surveillance System). Am J Infect Control. 2003;31:316-21. doi:10.1067/mic.2003.66. (Pubitemid 36960668)
12. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-32. doi:10.1016/j.ajic. 2008.03.002. (Pubitemid 351763841)
13. Krause R, Valentin T, Salzer H, Hönigl M, Valentin A, Auner H, et al. Which lumen is the source of catheter-related bloodstream infection in patients with multi-lumen central venous catheters? Infection. 2013;41:49-52.
14. van der Kooi TI, Wille JC, van Benthem BH. Catheter application, insertion vein and length of ICU stay prior to insertion affect the risk of catheter-related bloodstream infection. J Hosp Infect. 2012;80:238-44. doi:10.1016/j.jhin.2011.11.012.
15. Graves N, Barnett AG, Halton K, Crnich C, Cooper B, Beyersmann J, et al. The importance of good data, analysis, and interpretation for showing the economics of reducing healthcare-associated infection. Infect Control Hosp Epidemiol. 2011;32:927-8. doi:10.1086/661600 (author reply 8-30).
16. Tacconelli E, Smith G, Hieke K, Lafuma A, Bastide P. Epidemiology, medical outcomes and costs of catheter-related bloodstream infections in intensive care units of four European countries: literature- and registry-based estimates. J Hosp Infect. 2009;72:97-103. doi:10.1016/j.jhin.2008.12.012.
17. Eber MR, Laxminarayan R, Perencevich EN, Malani A. Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Arch Intern Med. 2010;170:347-53. doi:10.1001/archinternmed.2009.509.
18. Rosenthal VD, Guzman S, Migone O, Crnich CJ. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: a prospective, matched analysis. Am J Infect Control. 2003;31:475-80. doi:10.1016/j.ajic.2003.03.002. (Pubitemid 37533216)
19. Orsi GB, Di Stefano L, Noah N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol. 2002;23:190-7. doi:10.1086/502034. (Pubitemid 34297272)